Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Platelet IgG antibodies are significantly increased in chronic liver disease.

Annals of gastroenterology

Christodoulou D, Katsanos K, Zervou E, Theopistos V, Papathanasopoulos A, Christou L, Tsianos EV.
PMID: 24714308
Ann Gastroenterol. 2011;24(1):47-52.

BACKGROUND: The aim of this study was to investigate the presence of IgG antiplatelet (anti-P) IgG antibodies in patients with chronic liver disease (CLD) of diverse but well defined etiology.METHODS: One-hundred fifty-six consecutive patients with CLD (65 with chronic...

Cite
Christodoulou D, Katsanos K, Zervou E, et al. Platelet IgG antibodies are significantly increased in chronic liver disease. Ann Gastroenterol. 2011;24(1):47-52
Christodoulou, D., Katsanos, K., Zervou, E., Theopistos, V., Papathanasopoulos, A., Christou, L., & Tsianos, E. V. (2011). Platelet IgG antibodies are significantly increased in chronic liver disease. Annals of gastroenterology, 24(1), 47-52.
Christodoulou, Dimitrios, et al. "Platelet IgG antibodies are significantly increased in chronic liver disease." Annals of gastroenterology vol. 24,1 (2011): 47-52.
Christodoulou D, Katsanos K, Zervou E, Theopistos V, Papathanasopoulos A, Christou L, Tsianos EV. Platelet IgG antibodies are significantly increased in chronic liver disease. Ann Gastroenterol. 2011;24(1):47-52. PMID: 24714308; PMCID: PMC3959471.
Copy Download .nbib Format: NLM
Recurrence of choledocholithiasis following endoscopic bile duct clearance: Long term results and factors associated with recurrent bile duct stones.

World journal of gastrointestinal endoscopy

Konstantakis C, Triantos C, Theopistos V, Theocharis G, Maroulis I, Diamantopoulou G, Thomopoulos K.
PMID: 28101305
World J Gastrointest Endosc. 2017 Jan 16;9(1):26-33. doi: 10.4253/wjge.v9.i1.26.

AIM: To evaluate the rate of recurrence of symptomatic choledocholithiasis and identify factors associated with the recurrence of bile duct stones in patients who underwent endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic sphincterotomy (EST) for bile duct stone disease.METHODS: All...

Cite
Konstantakis C, Triantos C, Theopistos V, et al. Recurrence of choledocholithiasis following endoscopic bile duct clearance: Long term results and factors associated with recurrent bile duct stones. World J Gastrointest Endosc. 2017;9(1):26-33doi: 10.4253/wjge.v9.i1.26.
Konstantakis, C., Triantos, C., Theopistos, V., Theocharis, G., Maroulis, I., Diamantopoulou, G., & Thomopoulos, K. (2017). Recurrence of choledocholithiasis following endoscopic bile duct clearance: Long term results and factors associated with recurrent bile duct stones. World journal of gastrointestinal endoscopy, 9(1), 26-33. https://doi.org/10.4253/wjge.v9.i1.26
Konstantakis, Christos, et al. "Recurrence of choledocholithiasis following endoscopic bile duct clearance: Long term results and factors associated with recurrent bile duct stones." World journal of gastrointestinal endoscopy vol. 9,1 (2017): 26-33. doi: https://doi.org/10.4253/wjge.v9.i1.26
Konstantakis C, Triantos C, Theopistos V, Theocharis G, Maroulis I, Diamantopoulou G, Thomopoulos K. Recurrence of choledocholithiasis following endoscopic bile duct clearance: Long term results and factors associated with recurrent bile duct stones. World J Gastrointest Endosc. 2017 Jan 16;9(1):26-33. doi: 10.4253/wjge.v9.i1.26. PMID: 28101305; PMCID: PMC5215116.
Copy Download .nbib Format: NLM
Pancreatic Involvement in Inflammatory Bowel Disease: A Review.

Journal of clinical medicine research

Fousekis FS, Theopistos VI, Katsanos KH, Christodoulou DK.
PMID: 30214645
J Clin Med Res. 2018 Oct;10(10):743-751. doi: 10.14740/jocmr3561w. Epub 2018 Sep 10.

Inflammatory bowel disease (IBD) is a multisystemic disease, and pancreatic manifestations of IBD are not uncommon. The incidence of several pancreatic diseases in Crohn's disease and ulcerative colitis is more frequent compared to the general population. Pancreatic manifestations in...

Cite
Fousekis FS, Theopistos VI, Katsanos KH, et al. Pancreatic Involvement in Inflammatory Bowel Disease: A Review. J Clin Med Res. 2018;10(10):743-751doi: 10.14740/jocmr3561w.
Fousekis, F. S., Theopistos, V. I., Katsanos, K. H., & Christodoulou, D. K. (2018). Pancreatic Involvement in Inflammatory Bowel Disease: A Review. Journal of clinical medicine research, 10(10), 743-751. https://doi.org/10.14740/jocmr3561w
Fousekis, Fotios S, et al. "Pancreatic Involvement in Inflammatory Bowel Disease: A Review." Journal of clinical medicine research vol. 10,10 (2018): 743-751. doi: https://doi.org/10.14740/jocmr3561w
Fousekis FS, Theopistos VI, Katsanos KH, Christodoulou DK. Pancreatic Involvement in Inflammatory Bowel Disease: A Review. J Clin Med Res. 2018 Oct;10(10):743-751. doi: 10.14740/jocmr3561w. Epub 2018 Sep 10. PMID: 30214645; PMCID: PMC6135003.
Copy Download .nbib Format: NLM
Non-Operative Management of Type 2 ERCP-Related Retroperitoneal Duodenal Perforations: A 9-Year Experience From a Single Center.

Gastroenterology research

Theopistos V, Theocharis G, Konstantakis C, Kitrou P, Kehagias I, Triantos C, Thomopoulos K.
PMID: 29915631
Gastroenterology Res. 2018 Jun;11(3):207-212. doi: 10.14740/gr1007w. Epub 2018 May 31.

BACKGROUND: No consensus exists on treatment of endoscopic retrograde cholangiopancreatography (ERCP) -related, retroperitoneal duodenal perforations. The aim of this study is to determine the incidence of post-ERCP retroperitoneal periampullary (type 2) duodenal perforations and the clinical outcome of non-surgical...

Cite
Theopistos V, Theocharis G, Konstantakis C, et al. Non-Operative Management of Type 2 ERCP-Related Retroperitoneal Duodenal Perforations: A 9-Year Experience From a Single Center. Gastroenterology Res. 2018;11(3):207-212doi: 10.14740/gr1007w.
Theopistos, V., Theocharis, G., Konstantakis, C., Kitrou, P., Kehagias, I., Triantos, C., & Thomopoulos, K. (2018). Non-Operative Management of Type 2 ERCP-Related Retroperitoneal Duodenal Perforations: A 9-Year Experience From a Single Center. Gastroenterology research, 11(3), 207-212. https://doi.org/10.14740/gr1007w
Theopistos, Vasileios, et al. "Non-Operative Management of Type 2 ERCP-Related Retroperitoneal Duodenal Perforations: A 9-Year Experience From a Single Center." Gastroenterology research vol. 11,3 (2018): 207-212. doi: https://doi.org/10.14740/gr1007w
Theopistos V, Theocharis G, Konstantakis C, Kitrou P, Kehagias I, Triantos C, Thomopoulos K. Non-Operative Management of Type 2 ERCP-Related Retroperitoneal Duodenal Perforations: A 9-Year Experience From a Single Center. Gastroenterology Res. 2018 Jun;11(3):207-212. doi: 10.14740/gr1007w. Epub 2018 May 31. PMID: 29915631; PMCID: PMC5997477.
Copy Download .nbib Format: NLM
Acute Lower Gastrointestinal Bleeding in Patients Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice: Characteristics and Clinical Outcome.

Gastroenterology research

Diamantopoulou G, Konstantakis C, Skroubis G, Theocharis G, Theopistos V, Triantos C, Thomopoulos K.
PMID: 30834031
Gastroenterology Res. 2019 Feb;12(1):21-26. doi: 10.14740/gr1115. Epub 2019 Feb 26.

BACKGROUND: Acute lower gastrointestinal bleeding (ALGIB) can occur in patients on anticoagulant therapy (either warfarin or non-vitamin K oral anticoagulants (NOACs)). Use of NOACs has been increasing compared to warfarin in recent years. We analyzed patients with ALGIB on...

Cite
Diamantopoulou G, Konstantakis C, Skroubis G, et al. Acute Lower Gastrointestinal Bleeding in Patients Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice: Characteristics and Clinical Outcome. Gastroenterology Res. 2019;12(1):21-26doi: 10.14740/gr1115.
Diamantopoulou, G., Konstantakis, C., Skroubis, G., Theocharis, G., Theopistos, V., Triantos, C., & Thomopoulos, K. (2019). Acute Lower Gastrointestinal Bleeding in Patients Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice: Characteristics and Clinical Outcome. Gastroenterology research, 12(1), 21-26. https://doi.org/10.14740/gr1115
Diamantopoulou, Georgia, et al. "Acute Lower Gastrointestinal Bleeding in Patients Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice: Characteristics and Clinical Outcome." Gastroenterology research vol. 12,1 (2019): 21-26. doi: https://doi.org/10.14740/gr1115
Diamantopoulou G, Konstantakis C, Skroubis G, Theocharis G, Theopistos V, Triantos C, Thomopoulos K. Acute Lower Gastrointestinal Bleeding in Patients Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice: Characteristics and Clinical Outcome. Gastroenterology Res. 2019 Feb;12(1):21-26. doi: 10.14740/gr1115. Epub 2019 Feb 26. PMID: 30834031; PMCID: PMC6396796.
Copy Download .nbib Format: NLM
Irritable bowel syndrome might be associated with dry eye disease.

Annals of gastroenterology

Asproudis I, Tsoumani AT, Katsanos KH, Katsanos AH, Theopistos V, Paschidis KA, Tsianos EV, Christodoulou D.
PMID: 27708515
Ann Gastroenterol. 2016 Oct-Dec;29(4):487-491. doi: 10.20524/aog.2016.0064. Epub 2016 Jun 16.

BACKGROUND: A possible association between dry eye disease (DED) and irritable bowel syndrome (IBS) has been hypothesized based on the fact that they both share an inflammatory pathogenesis.METHODS: Ninety-five patients with IBS and 276 healthy controls were enrolled in...

Cite
Asproudis I, Tsoumani AT, Katsanos KH, et al. Irritable bowel syndrome might be associated with dry eye disease. Ann Gastroenterol. 2016;29(4):487-491doi: 10.20524/aog.2016.0064.
Asproudis, I., Tsoumani, A. T., Katsanos, K. H., Katsanos, A. H., Theopistos, V., Paschidis, K. A., Tsianos, E. V., & Christodoulou, D. (2016). Irritable bowel syndrome might be associated with dry eye disease. Annals of gastroenterology, 29(4), 487-491. https://doi.org/10.20524/aog.2016.0064
Asproudis, Ioannis, et al. "Irritable bowel syndrome might be associated with dry eye disease." Annals of gastroenterology vol. 29,4 (2016): 487-491. doi: https://doi.org/10.20524/aog.2016.0064
Asproudis I, Tsoumani AT, Katsanos KH, Katsanos AH, Theopistos V, Paschidis KA, Tsianos EV, Christodoulou D. Irritable bowel syndrome might be associated with dry eye disease. Ann Gastroenterol. 2016 Oct-Dec;29(4):487-491. doi: 10.20524/aog.2016.0064. Epub 2016 Jun 16. PMID: 27708515; PMCID: PMC5049556.
Copy Download .nbib Format: NLM
Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.

Gastroenterology research

Fousekis FS, Theopistos VI, Katsanos KH, Tsianos EV, Christodoulou DK.
PMID: 29707074
Gastroenterology Res. 2018 Apr;11(2):83-94. doi: 10.14740/gr990w. Epub 2018 Apr 07.

Liver and biliary track diseases are common extraintestinal manifestations of inflammatory bowel disease (IBD), reported both in Crohn's disease and ulcerative colitis, and may occur at any time during the natural course of the disease. Their etiology is mainly...

Cite
Fousekis FS, Theopistos VI, Katsanos KH, et al. Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review. Gastroenterology Res. 2018;11(2):83-94doi: 10.14740/gr990w.
Fousekis, F. S., Theopistos, V. I., Katsanos, K. H., Tsianos, E. V., & Christodoulou, D. K. (2018). Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review. Gastroenterology research, 11(2), 83-94. https://doi.org/10.14740/gr990w
Fousekis, Fotios S, et al. "Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review." Gastroenterology research vol. 11,2 (2018): 83-94. doi: https://doi.org/10.14740/gr990w
Fousekis FS, Theopistos VI, Katsanos KH, Tsianos EV, Christodoulou DK. Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review. Gastroenterology Res. 2018 Apr;11(2):83-94. doi: 10.14740/gr990w. Epub 2018 Apr 07. PMID: 29707074; PMCID: PMC5916631.
Copy Download .nbib Format: NLM
Endoscopic ultrasonography in pancreatic diseases: advances in tissue acquisition.

Endoscopy international open

Mitselos IV, Karoumpalis I, Theopistos VI, Tzilves D, Christodoulou DK.
PMID: 31304238
Endosc Int Open. 2019 Jul;7(7):E922-E930. doi: 10.1055/a-0915-9594. Epub 2019 Jul 11.

No abstract available.

Cite
Mitselos IV, Karoumpalis I, Theopistos VI, et al. Endoscopic ultrasonography in pancreatic diseases: advances in tissue acquisition. Endosc Int Open. 2019;7(7):E922-E930doi: 10.1055/a-0915-9594.
Mitselos, I. V., Karoumpalis, I., Theopistos, V. I., Tzilves, D., & Christodoulou, D. K. (2019). Endoscopic ultrasonography in pancreatic diseases: advances in tissue acquisition. Endoscopy international open, 7(7), E922-E930. https://doi.org/10.1055/a-0915-9594
Mitselos, Ioannis V, et al. "Endoscopic ultrasonography in pancreatic diseases: advances in tissue acquisition." Endoscopy international open vol. 7,7 (2019): E922-E930. doi: https://doi.org/10.1055/a-0915-9594
Mitselos IV, Karoumpalis I, Theopistos VI, Tzilves D, Christodoulou DK. Endoscopic ultrasonography in pancreatic diseases: advances in tissue acquisition. Endosc Int Open. 2019 Jul;7(7):E922-E930. doi: 10.1055/a-0915-9594. Epub 2019 Jul 11. PMID: 31304238; PMCID: PMC6624111.
Copy Download .nbib Format: NLM
Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.

Journal of clinical medicine research

Fousekis FS, Theopistos VI, Mitselos IV, Skamnelos A, Kavvadias A, Katsanos KH, Christodoulou DK.
PMID: 30700999
J Clin Med Res. 2019 Feb;11(2):81-88. doi: 10.14740/jocmr3680. Epub 2019 Jan 05.

Primary sclerosing cholangitis (PSC) is a chronic and progressive disease of the biliary tract. PSC is strongly associated with inflammatory bowel disease (IBD), mainly with ulcerative colitis, and most PSC patients have underlying IBD. The pathophysiological interactions between IBD...

Cite
Fousekis FS, Theopistos VI, Mitselos IV, et al. Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. J Clin Med Res. 2019;11(2):81-88doi: 10.14740/jocmr3680.
Fousekis, F. S., Theopistos, V. I., Mitselos, I. V., Skamnelos, A., Kavvadias, A., Katsanos, K. H., & Christodoulou, D. K. (2019). Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Journal of clinical medicine research, 11(2), 81-88. https://doi.org/10.14740/jocmr3680
Fousekis, Fotios S, et al. "Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis." Journal of clinical medicine research vol. 11,2 (2019): 81-88. doi: https://doi.org/10.14740/jocmr3680
Fousekis FS, Theopistos VI, Mitselos IV, Skamnelos A, Kavvadias A, Katsanos KH, Christodoulou DK. Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. J Clin Med Res. 2019 Feb;11(2):81-88. doi: 10.14740/jocmr3680. Epub 2019 Jan 05. PMID: 30700999; PMCID: PMC6340671.
Copy Download .nbib Format: NLM
Acute Lower Gastrointestinal Bleeding: Characteristics and Clinical Outcome of Patients Treated With an Intensive Protocol.

Gastroenterology research

Diamantopoulou G, Konstantakis C, Kottorοu A, Skroubis G, Theocharis G, Theopistos V, Triantos C, Nikolopoulou V, Thomopoulos K.
PMID: 29317943
Gastroenterology Res. 2017 Dec;10(6):352-358. doi: 10.14740/gr914w. Epub 2018 Jan 03.

BACKGROUND: In recent years major advances have been made in the management of patients with acute lower gastrointestinal bleeding. The aim of this study was to investigate the characteristics and clinical outcome of patients with acute lower gastrointestinal bleeding...

Cite
Diamantopoulou G, Konstantakis C, Kottorοu A, et al. Acute Lower Gastrointestinal Bleeding: Characteristics and Clinical Outcome of Patients Treated With an Intensive Protocol. Gastroenterology Res. 2018;10(6):352-358doi: 10.14740/gr914w.
Diamantopoulou, G., Konstantakis, C., Kottorοu, A., Skroubis, G., Theocharis, G., Theopistos, V., Triantos, C., Nikolopoulou, V., & Thomopoulos, K. (2017). Acute Lower Gastrointestinal Bleeding: Characteristics and Clinical Outcome of Patients Treated With an Intensive Protocol. Gastroenterology research, 10(6), 352-358. https://doi.org/10.14740/gr914w
Diamantopoulou, Georgia, et al. "Acute Lower Gastrointestinal Bleeding: Characteristics and Clinical Outcome of Patients Treated With an Intensive Protocol." Gastroenterology research vol. 10,6 (2017): 352-358. doi: https://doi.org/10.14740/gr914w
Diamantopoulou G, Konstantakis C, Kottorοu A, Skroubis G, Theocharis G, Theopistos V, Triantos C, Nikolopoulou V, Thomopoulos K. Acute Lower Gastrointestinal Bleeding: Characteristics and Clinical Outcome of Patients Treated With an Intensive Protocol. Gastroenterology Res. 2017 Dec;10(6):352-358. doi: 10.14740/gr914w. Epub 2018 Jan 03. PMID: 29317943; PMCID: PMC5755637.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries